Skip to search formSkip to main contentSkip to account menu

lidamycin

National Institutes of Health

Related topics

Related topics

1 relation

Narrower (1)

C 1027

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Lidamycin inhibits tumor initiating cells of hepatocellular carcinoma Huh7 through GSK3β/β‐catenin pathway
Recently, tumor initiating cells are considered as the central role of tumorigenicity in hepatocellular carcinoma. Enediyne… 
2013
2013
An NGR-integrated and enediyne-energized apoprotein shows CD13-targeting antitumor activity.
2012
2012
A cell penetrating peptide-integrated and enediyne-energized fusion protein shows potent antitumor activity.
2009
2009
Enediyne lidamycin induces apoptosis in human multiple myeloma cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase
In the present study, the effects of lidamycin (LDM), a member of the enediyne antibiotic family, on two human multiple myeloma… 
2007
2007
Lidamycin induces marked G2 cell cycle arrest in human colon carcinoma HT-29 cells through activation of p38 MAPK pathway.
Lidamycin (LDM), a member of the enediyne antibiotic family, is presently undergoing phase I clinical trials in P.R. China. In… 
2007
2007
Generation and antitumor effects of an engineered and energized fusion protein VL-LDP-AE composed of single-domain antibody and lidamycin
Type IV collagenase plays a pivotal role in invasion, metastasis and angiogenesis of tumor. Single domain antibodies are… 
2005
2005
Antitumor activity of anti-type IV collagenase monoclonal antibody and its lidamycin conjugate against colon carcinoma.
AIM Type IV collagenase including MMP-2 and -9 plays an important role in cancer cell invasion and metastasis and is an… 
2004
2004
Mitotic cell death in BEL-7402 cells induced by enediyne antibiotic lidamycin is associated with centrosome overduplication.
AIM Mitotic cell death has been focused on in tumor therapy. However, the precise mechanisms underlying it remain unclear. We… 
2003
2003
[Antitumor effects of the immunoconjugate composed of lidamycin and monoclonal antibody 3G11].
AIM To study the antitumor effects of an immunoconjugate composed of lidamycin (LDM) and monoclonal antibody 3G11 (3G11-LDM… 
2002
2002
Characteristics of mitotic cell death induced by enediyne antibiotic lidamycin in human epithelial tumor cells.
Mitotic cell death, a different cell death mode from apoptosis, has been focused on in tumor therapy. It may involve the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)